HomeCompareTHCHW vs MRK

THCHW vs MRK: Dividend Comparison 2026

THCHW yields 357.14% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 THCHW wins by $5052.70M in total portfolio value
10 years
THCHW
THCHW
● Live price
357.14%
Share price
$0.56
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5052.76M
Annual income
$3,258,159,373.38
Full THCHW calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — THCHW vs MRK

📍 THCHW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTHCHWMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, THCHW + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
THCHW pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

THCHW
Annual income on $10K today (after 15% tax)
$30,357.14/yr
After 10yr DRIP, annual income (after tax)
$2,769,435,467.37/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, THCHW beats the other by $2,769,427,138.96/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of THCHW + MRK for your $10,000?

THCHW: 50%MRK: 50%
100% MRK50/50100% THCHW
Portfolio after 10yr
$2526.41M
Annual income
$1,629,084,585.76/yr
Blended yield
64.48%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

THCHW
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

THCHW buys
0
MRK buys
0
No recent congressional trades found for THCHW or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTHCHWMRK
Forward yield357.14%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$5052.76M$56.8K
Annual income after 10y$3,258,159,373.38$9,798.13
Total dividends collected$4882.23M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: THCHW vs MRK ($10,000, DRIP)

YearTHCHW PortfolioTHCHW Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$46,414$35,714.29$11,206$366.19+$35.2KTHCHW
2$204,584$154,920.85$12,650$502.35+$191.9KTHCHW
3$857,090$638,184.66$14,407$694.19+$842.7KTHCHW
4$3,415,802$2,498,716.02$16,585$967.82+$3.40MTHCHW
5$12,961,690$9,306,782.07$19,342$1,363.89+$12.94MTHCHW
6$46,874,387$33,005,378.45$22,913$1,947.19+$46.85MTHCHW
7$161,706,963$111,551,368.72$27,662$2,823.89+$161.68MTHCHW
8$532,679,912$359,653,461.86$34,159$4,173.35+$532.65MTHCHW
9$1,677,198,072$1,107,230,566.48$43,337$6,308.80+$1677.15MTHCHW
10$5,052,761,311$3,258,159,373.38$56,776$9,798.13+$5052.70MTHCHW

THCHW vs MRK: Complete Analysis 2026

THCHWStock

TH International Limited operates Tim Hortons coffee shops in mainland China, Hong Kong, and Macau. As of September 28, 2022, it had approximately 460 coffee shops across the People's Republic of China. The company was incorporated in 2018 and is based in Shanghai, the People's Republic of China. TH International Limited is a subsidiary of Tim Hortons Inc.

Full THCHW Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this THCHW vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

THCHW vs SCHDTHCHW vs JEPITHCHW vs OTHCHW vs KOTHCHW vs MAINTHCHW vs JNJTHCHW vs ABBVTHCHW vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.